Management of patients with peripheral arterial disease in primary care: a cross-sectional study in Germany

被引:7
|
作者
Kroeger, K. [1 ]
Schwertfeger, M. [2 ]
Pittrow, D. [3 ]
Diehm, C. [4 ]
机构
[1] HELIOS Klinikum Krefeld GmbH, Klin Angiol Interdisziplinaren Gefazentrum, Dept Angiol, D-47805 Krefeld, Germany
[2] Sanofi Aventis Deutschland GmbH, Dept Med, Berlin, Germany
[3] Tech Univ Dresden, Fac Med, Inst Clin Pharmacol, Dresden, Germany
[4] Heidelberg Univ, SRH Klinikum gGmbH, Acad Teaching Hosp, Dept Internal Med, Karlsbad, Germany
关键词
CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; ORAL ANTICOAGULANT; RISK; PREVALENCE; PREVENTION; INFARCTION; MORBIDITY; MORTALITY; THERAPY;
D O I
10.1111/j.1742-1241.2010.02337.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P>Background: Studies in the primary care setting are of high interest for assessing the management situation of patients with manifestations of atherothrombosis. Aims: Therefore, we documented diagnostic procedures, characteristics, and management of patients with symptomatic and asymptomatic peripheral arterial disease (PAD). Materials & Methods: Prospective cross-sectional study in primary care practices throughout Germany. Results: A total of 671 patients with newly diagnosed PAD were included (mean age 69.1 years; 62.1% men). Cardiovascular risk factors were highly prevalent in the total PAD group: arterial hypertension in 84.2%, hyperlipidaemia in 75.5%, present smoking in 45.0% and diabetes mellitus in 47.3%. Atherothrombotic comorbidities were also frequent: coronary artery disease in 44.9% and cerebrovascular disease in 28.1%. For confirmation of diagnosis, patients were referred to specialists in 66.9% of cases. Overall, ankle brachial index was measured in 89.0%, and a clinical PAD score assessed in 66.6% (agreement of both measures with Cohen's kappa only, kappa = 0.039; p = 0.209). Drug treatment of risk factors (as secondary prophylaxis) in line with current guidelines was reported in a high percentage of patients: 88.6% with any antiplatelet drug, 69.3% with statins, 62.4% with angiotensin converting enzyme inhibitors, 23.5% with AT(1) receptor blockers and 43.9% with beta-blockers. Between asymptomatic and symptomatic PAD, differences in the risk factor/comorbidity profiles were small; however, the latter group received intensified treatment. Conclusion: Our findings confirm that patients with PAD pose a substantial challenge to physicians because of their high number of comorbidities. Compared with previous studies, management of such patients appears to have improved.
引用
收藏
页码:875 / 884
页数:10
相关论文
共 50 条
  • [1] Primary care screening for peripheral arterial disease: a cross-sectional observational study
    Davies, Jane H.
    Richards, Jonathan
    Conway, Kevin
    Kenkre, Joyce E.
    Lewis, Jane E. A.
    Williams, E. Mark
    BRITISH JOURNAL OF GENERAL PRACTICE, 2017, 67 (655): : E103 - E110
  • [2] High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study
    Diehm, C
    Schuster, A
    Allenberg, JR
    Darius, H
    Haberl, R
    Lange, S
    Pittrow, D
    von Stritzky, B
    Tepohl, G
    Trampisch, HJ
    ATHEROSCLEROSIS, 2004, 172 (01) : 95 - 105
  • [3] Are elevated homocysteine plasma levels related to peripheral arterial disease? Results from a cross-sectional study of 6880 primary care patients
    Darius, H
    Pittrow, D
    Haberl, R
    Trampisch, HJ
    Schuster, A
    Lange, S
    Tepohl, HG
    Allenberg, JR
    Diehm, C
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 (09) : 751 - 757
  • [4] Frequency and management of emergencies in primary care offices: A cross-sectional study in northwestern Germany
    Melzel, Max
    Hoffmann, Falk
    Freitag, Michael H.
    Spreckelsen, Ove
    EUROPEAN JOURNAL OF GENERAL PRACTICE, 2022, 28 (01) : 209 - 216
  • [5] Distribution of Mobile Health Applications amongst Patients with Symptomatic Peripheral Arterial Disease in Germany: A Cross-Sectional Survey Study
    Alushi, Kastriot
    Hinterseher, Irene
    Peters, Frederik
    Rother, Ulrich
    Bischoff, Moritz S.
    Mylonas, Spyridon
    Grambow, Eberhard
    Gombert, Alexander
    Busch, Albert
    Gray, Daphne
    Konstantinou, Nikolaos
    Stavroulakis, Konstantinos
    Horn, Marco
    Goertz, Hartmut
    Uhl, Christian
    Federrath, Hannes
    Trute, Hans-Heinrich
    Kreutzburg, Thea
    Behrendt, Christian-Alexander
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (03)
  • [6] A cross sectional survey of secondary prevention measures in patients with peripheral arterial disease in primary care
    Dunkley, Alison
    Stone, Margaret
    Sayers, Robert
    Farooqi, Azhar
    Khunti, Kamlesh
    POSTGRADUATE MEDICAL JOURNAL, 2007, 83 (983) : 602 - 605
  • [7] Statins and biomarkers in claudicants with peripheral arterial disease: Cross-sectional study
    DePalma, Ralph G.
    Hayes, Virginia W.
    May, Patricia E.
    Cafferata, H. Treat
    Mohammadpour, Hamid A.
    Brigg, Laura A.
    Chow, Bruce K.
    Shamayeva, Galina
    Zacharski, Leo R.
    VASCULAR, 2006, 14 (04) : 193 - 200
  • [8] Prevalence, clinical characteristics, and predictors of peripheral arterial disease in hemodialysis patients: a cross-sectional study
    Asceric, Radislav R.
    Dimkovic, Nada B.
    Trajkovic, Goran Z.
    Ristic, Biljana S.
    Jankovic, Aleksandar N.
    Duric, Petar S.
    Ilijevski, Nenad S.
    BMC NEPHROLOGY, 2019, 20 (1)
  • [9] Prevalence, clinical characteristics, and predictors of peripheral arterial disease in hemodialysis patients: a cross-sectional study
    Radislav R. Ašćerić
    Nada B. Dimković
    Goran Ž. Trajković
    Biljana S. Ristić
    Aleksandar N. Janković
    Petar S. Durić
    Nenad S. Ilijevski
    BMC Nephrology, 20
  • [10] Experiences of patients with multimorbidity with primary care and the association with patient activation: a cross-sectional study in Germany
    Breckner, Amanda
    Glassen, Katharina
    Schulze, Josefine
    Luhmann, Dagmar
    Schaefer, Ingmar
    Szecsenyi, Joachim
    Scherer, Martin
    Wensing, Michel
    BMJ OPEN, 2022, 12 (08):